Showing results (1821-1830 of 4,267) with videos related to
Sort By:
Pageof 427
The Journal of Clinical Investigation|April 1, 1995
Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generationA J Coyle, S J Ackerman, R Burch, et al.Breast Cancer Research and Treatment|June 30, 2005
An ecological study of the association of environmental chemicals on breast cancer incidence in TexasYvonne M Coyle, Linda S Hynan, David M Euhus, et al.American Journal of Botany|July 13, 2018
Bioclimatic factors at an intrabiome scale are more limiting than cyanobiont availability for the lichen-forming genus PeltigeraJade Lu, Nicolas Magain, Jolanta Miadlikowska, et al.Cancer Nursing|August 1, 1989
Guidelines for use of controlled-release oral morphine in cancer pain management. Correlation with clinical experienceJ Lapin, R K Portenoy, N Coyle, et al.Nature Structural & Molecular Biology|January 26, 2010
Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylationMartin Jinek, Marc R Fabian, Scott M Coyle, et al.The Journal of School Health|December 11, 2013
"They were only joking": efforts to decrease LGBTQ bullying and harassment in seattle public schoolsPamela Hillard, Lisa Love, Heather M Franks, et al.Allergy|July 28, 2009
Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammationF Perros, H C Hoogsteden, A J Coyle, et al.Patient Education and Counseling|June 16, 2010
Is the routine recording of primary care consultations possible … and desirable? Lessons for researchers from a consultation with multiple stakeholdersRosemary Rushmer, Mark Themessel-Huber, Joanne Coyle, et al.Drug and Alcohol Dependence|November 2, 2010
Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaireM J Baggott, J R Coyle, E Erowid, et al.Journal of Medicinal Chemistry|June 23, 2011
Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG)Jamin D Steffen, Donna L Coyle, Komath Damodaran, et al.Pageof 427